(Q34184939)

English

The death of cost-minimization analysis?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

The death of cost-minimization analysis? (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Briggs AH

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

O'Brien BJ

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Health Economics

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

179-184

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs and cost-minimisation analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-utility analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Carrier screening for cystic fibrosis: costs and clinical outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of health care policy initiatives on productivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistics notes: Absence of evidence is not evidence of absence

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH)

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical inference for cost-effectiveness ratios.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.584

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEC.584

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34184939&oldid=1953009760"